PremiumCompany AnnouncementsDr. Reddy’s Laboratories Releases Audited Financial Results for March 2025 Dr. Reddy’s Laboratories Releases Earnings Call Audio for Q1 2025 Dr. Reddy’s Reports FY2025 Results and Announces Key Appointments PremiumCompany AnnouncementsDr. Reddy’s Laboratories Responds to Speculation on Sanofi’s Insulin Brand Sale Dr. Reddy’s Refutes Workforce Cost Reduction Claims Dr. Reddy’s says report of 25% workforce cost reduction ‘incorrect’ PremiumThe FlyDr. Reddy’s, Alvotech announce FDA acceptance of AVT03 BLA Dr. Reddy’s, Alvotech announce FDA acceptance of BLA for AVT03 Dr. Reddy’s Recalls Mislabelled Levetiracetam Injection in U.S.